The Executive Board

(Click on the images below to view a brief biography of each Board member)

Stefan Oschmann Bernd Reckmann Karl-Ludwig Kley Kai Beckmann Matthias Zachert

Stefan Oschmann – Head of the Pharmaceuticals business sector

Bernd Reckmann – Head of the Chemicals business sector

Karl-Ludwig Kley – Chairman of the Executive Board

Kai Beckmann – Head of Group Human Resources / Chief Administration Officer

Matthias Zachert – Chief Financial Officer

Stefan Oschmann – Head of the Pharmaceuticals business sector

  • Born in 1957, veterinarian
  • Member of the Executive Board since January 2011
  • Responsibility for Group functions: Patents & Scientific Information
  • Regional responsibility: North America and Latin America

Bernd Reckmann – Head of the Chemicals business sector

  • Born in 1955, biochemist
  • Joined Merck in 1986, member of the Executive Board since 2007
  • Responsibility for Group functions: Quality Management; Logistics and Supply Chain
  • Regional responsibility: Asia-Pacific

Karl-Ludwig Kley – Chairman of the Executive Board

  • Born in 1951, lawyer
  • Member of the Supervisory Board and Board of Partners of Merck from March 2004 to June 2006; member of the Executive Board since September 2006
  • Responsibility for Group functions: Group Strategy; Group Communications; Group Legal and Compliance; Group Auditing

Kai Beckmann – Head of Group Human Resources / Chief Administration Officer

  • Born in 1965, university degree in computer science
  • Joined Merck in 1989, member of the Executive Board since April 2011
  • Responsibility for Group functions: Group Human Resources; Group Information Services; Site Management Darmstadt and Gernsheim; Inhouse Consulting
  • Regional responsibilities: EMEA (Europe, Middle East, Africa)

Matthias Zachert – Chief Financial Officer

  • Born in 1967, university degree in business administration
  • Member of the Executive Board since June 2011
  • Responsibility for Group functions: Group Accounting & Subsidiaries; Group Controlling; Group Finance; Group Taxes; Group Insurance; Group Procurement; Investor Relations